MedTrace Logo

Tea and Forearm Blood Flow

NCT02328339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-08-31

No results posted yet for this study

Summary

The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar a placebo matched for taste and appearance in a blinded cross over design.

Conditions

  • Vascular Function

Interventions

OTHER

Tea

Black tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents

OTHER

Placebo

Placebo matched to tea with respect to taste and appearance

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Sean Roerink, Dr. · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02328339 on ClinicalTrials.gov